Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Peter Lawson is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/08/2024 | RCUS | Buy Now | Arcus Biosciences | $13.99 | 78.7% | $35 → $25 | Maintains | Overweight | Get Alert |
| 06/07/2024 | REPL | Buy Now | Replimune Group | $8.44 | 101.42% | $13 → $17 | Maintains | Overweight | Get Alert |
| 06/07/2024 | BMEA | Buy Now | Biomea Fusion | $4.74 | 5.49% | $30 → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/24/2024 | TNGX | Buy Now | Tango Therapeutics | $8.84 | 47.06% | $18 → $13 | Maintains | Overweight | Get Alert |
| 05/10/2024 | MGNX | Buy Now | Macrogenics | $4.23 | 230.98% | $25 → $14 | Maintains | Overweight | Get Alert |
| 05/10/2024 | RLAY | Buy Now | Relay Therapeutics | $6.50 | 130.77% | $15 → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/03/2024 | BPMC | Buy Now | Blueprint Medicines | $115.93 | -35.31% | $70 → $75 | Maintains | Equal-Weight | Get Alert |
| 04/30/2024 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $9 → $26 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/11/2024 | EXEL | Buy Now | Exelixis | $22.00 | 13.64% | $25 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/08/2024 | MGNX | Buy Now | Macrogenics | $4.23 | 491.03% | $23 → $25 | Maintains | Overweight | Get Alert |
| 03/07/2024 | TCRX | Buy Now | TScan Therapeutics | $5.82 | 54.64% | $7 → $9 | Maintains | Overweight | Get Alert |
| 02/29/2024 | ARVN | Buy Now | Arvinas | $25.68 | 133.64% | $26 → $60 | Maintains | Overweight | Get Alert |
| 02/29/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $7.28 | 202.2% | $18 → $22 | Maintains | Overweight | Get Alert |
| 02/29/2024 | MGNX | Buy Now | Macrogenics | $4.23 | 443.75% | $12 → $23 | Maintains | Overweight | Get Alert |
| 02/29/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $38.74 | 62.62% | $47 → $63 | Maintains | Overweight | Get Alert |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $3.10 | 222.57% | $6 → $10 | Maintains | Overweight | Get Alert |
| 02/13/2024 | BPMC | Buy Now | Blueprint Medicines | $115.93 | -39.62% | $58 → $70 | Maintains | Equal-Weight | Get Alert |
| 01/30/2024 | EXEL | Buy Now | Exelixis | $22.00 | 13.64% | $24 → $25 | Maintains | Overweight | Get Alert |
| 01/25/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $38.74 | 21.32% | $41 → $47 | Maintains | Overweight | Get Alert |
| 12/06/2023 | REPL | Buy Now | Replimune Group | $8.44 | 54.03% | $50 → $13 | Maintains | Overweight | Get Alert |
| 12/04/2023 | IMGN | Buy Now | Immunogen | — | — | $27 → $31 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/01/2023 | IMGN | Buy Now | Immunogen | — | — | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/27/2023 | BPMC | Buy Now | Blueprint Medicines | $115.93 | -49.97% | $46 → $58 | Maintains | Equal-Weight | Get Alert |
| 10/24/2023 | ARVN | Buy Now | Arvinas | $25.68 | 1.25% | $39 → $26 | Maintains | Overweight | Get Alert |
| 10/17/2023 | EXAI | Buy Now | Exscientia | $5.93 | 68.61% | $12 → $10 | Maintains | Overweight | Get Alert |
| 09/18/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $7.28 | 147.25% | $40 → $18 | Maintains | Overweight | Get Alert |
| 08/10/2023 | FATE | Buy Now | Fate Therapeutics | $3.10 | 93.54% | $12 → $6 | Maintains | Overweight | Get Alert |
| 08/10/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.20 | -16.67% | $2 → $1 | Maintains | Underweight | Get Alert |
| 08/09/2023 | ARVN | Buy Now | Arvinas | $25.68 | 51.87% | $70 → $39 | Maintains | Overweight | Get Alert |
| 08/04/2023 | PRLD | Buy Now | Prelude Therapeutics | $3.50 | 42.86% | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | EXEL | Buy Now | Exelixis | $22.00 | 9.09% | $25 → $24 | Maintains | Overweight | Get Alert |
| 08/02/2023 | IMGN | Buy Now | Immunogen | — | — | $20 → $27 | Maintains | Overweight | Get Alert |
| 07/26/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $21.89 | 55.29% | $31 → $34 | Maintains | Overweight | Get Alert |
| 06/12/2023 | IMGN | Buy Now | Immunogen | — | — | $9 → $20 | Maintains | Overweight | Get Alert |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | $115.93 | -60.32% | $44 → $46 | Maintains | Equal-Weight | Get Alert |
| 05/12/2023 | BMEA | Buy Now | Biomea Fusion | $4.74 | 954.85% | → $50 | Initiates | → Overweight | Get Alert |
| 04/28/2023 | SWTX | Buy Now | SpringWorks Therapeutics | $38.74 | 5.83% | $55 → $41 | Maintains | Overweight | Get Alert |
| 04/19/2023 | RLAY | Buy Now | Relay Therapeutics | $6.50 | 130.77% | $23 → $15 | Maintains | Equal-Weight | Get Alert |
| 03/09/2023 | NRIX | Buy Now | Nurix Therapeutics | $20.93 | -4.44% | → $20 | Initiates | → Overweight | Get Alert |
| 01/23/2023 | BPMC | Buy Now | Blueprint Medicines | $115.93 | -62.05% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
| 01/04/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $8 → $9 | Maintains | Underweight | Get Alert |
| 12/21/2022 | RCUS | Buy Now | Arcus Biosciences | $13.99 | 150.18% | $60 → $35 | Maintains | Overweight | Get Alert |
| 12/12/2022 | BPMC | Buy Now | Blueprint Medicines | $115.93 | -54.28% | $58 → $53 | Maintains | Equal-Weight | Get Alert |
| 11/30/2022 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 113.56% | → $80 | Initiates | → Overweight | Get Alert |
| 11/23/2022 | ARVN | Buy Now | Arvinas | $25.68 | 172.59% | $90 → $70 | Maintains | Overweight | Get Alert |
| 11/16/2022 | EXAI | Buy Now | Exscientia | $5.93 | 102.34% | $40 → $12 | Maintains | Overweight | Get Alert |
| 11/15/2022 | IMGN | Buy Now | Immunogen | — | — | $8 → $9 | Maintains | Overweight | Get Alert |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | $115.93 | -49.97% | $70 → $58 | Maintains | Equal-Weight | Get Alert |
| 09/30/2022 | RLAY | Buy Now | Relay Therapeutics | $6.50 | 253.85% | → $23 | Initiates | → Equal-Weight | Get Alert |
| 09/09/2022 | IMGN | Buy Now | Immunogen | — | — | → $8 | Initiates | → Overweight | Get Alert |
| 09/09/2022 | ARVN | Buy Now | Arvinas | $25.68 | 250.47% | → $90 | Initiates | → Overweight | Get Alert |
| 08/16/2022 | NEXI | Buy Now | NexImmune | $2.48 | -19.35% | $175 → $50 | Maintains | Overweight | Get Alert |
| 08/09/2022 | MGNX | Buy Now | Macrogenics | $4.23 | 89.13% | $18 → $8 | Maintains | Overweight | Get Alert |
| 08/05/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $0.81 | 892.93% | $14 → $8 | Maintains | Overweight | Get Alert |
| 07/28/2022 | BCYC | Buy Now | Bicycle Therapeutics | $20.23 | 48.29% | → $30 | Initiates | → Overweight | Get Alert |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $1.36 | 157.35% | $7 → $3.5 | Maintains | Overweight | Get Alert |
| 04/01/2022 | NEXI | Buy Now | NexImmune | $2.48 | 182.26% | $100 → $175 | Maintains | Overweight | Get Alert |
| 02/28/2022 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $11 → $6 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 02/28/2022 | PRLD | Buy Now | Prelude Therapeutics | $3.50 | 242.86% | $20 → $12 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/18/2022 | CTMX | Buy Now | CytomX Therapeutics | $1.36 | 414.71% | → $7 | Upgrade | Underweight → Overweight | Get Alert |
| 11/19/2021 | RCUS | Buy Now | Arcus Biosciences | $13.99 | 328.88% | — | Maintains | Overweight | Get Alert |
| 11/17/2021 | PRLD | Buy Now | Prelude Therapeutics | $3.50 | 471.43% | — | Maintains | Overweight | Get Alert |
| 07/14/2017 | AFMD | Buy Now | Affimed | $5.02 | 39.44% | → $70 | Initiates | → Buy | Get Alert |
